HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$6.64
Day range
$6.39 - $6.85
Year range
$3.51 - $16.95
Market cap
55.93M USD
Avg Volume
171.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 37.93M | -11.35% |
Operating expense | 28.48M | -8.35% |
Net income | -37.25M | -256.57% |
Net profit margin | -98.22 | -276.62% |
Earnings per share | -4.07 | 6.39% |
EBITDA | -24.31M | 13.27% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.70M | -66.02% |
Total assets | 104.88M | -50.99% |
Total liabilities | 343.80M | -0.67% |
Total equity | -238.93M | — |
Shares outstanding | 8.67M | — |
Price to book | -0.24 | — |
Return on assets | -52.42% | — |
Return on capital | -153.36% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -37.25M | -256.57% |
Cash from operations | -18.70M | 51.43% |
Cash from investing | 18.28M | -64.33% |
Cash from financing | 356.00K | -99.13% |
Net change in cash | -48.00K | -100.09% |
Free cash flow | -9.44M | 69.30% |
About
Founded
2008
Headquarters
Website
Employees
279
